Results 41 to 50 of about 77,174 (152)

The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line

open access: yesMiddle East Journal of Cancer, 2017
Background: Combination therapy has generated remarkable motivation in the clinical setting since it boosts the therapeutic potential of anticancer drugs.
Ashkan Zandi   +4 more
doaj  

Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Cyclin D1 (CCND1) is frequently overexpressed in malignant gliomas. We have previously shown ectopic overexpression of CCND1 in human malignant gliomas cell lines.
Danfeng Zhang   +7 more
doaj   +1 more source

Current chemotherapy strategies for adults with IDH-wildtype glioblastoma

open access: yesFrontiers in Oncology
IntroductionGlioblastoma, despite advancements in molecular evolution, remains incurable and has low survival rates. Currently, two of the most commonly used chemotherapy regimens are temozolomide and CCNU.
Jing Bao   +3 more
doaj   +1 more source

Toxicities and Associated Factors in Patients Receiving Temozolomide-Containing Regimens: A 12-Year Analysis of Hospital Data

open access: yesDrug Design, Development and Therapy, 2021
Chen Shi,1,2 Xiong Wang,1,2 Changdong Diao,1,2 Haixia Zhu,1,2 Qi Yuan,1,2 Jinmei Liu,1,2 Shijun Li,1,2 Ming Gu,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology (HUST), Wuhan,
Shi C   +8 more
doaj  

Temozolomide enhances PARP inhibitor sensitivity in multiple tumour types.

open access: yes, 2015
List of cell lines screened against a combination of olaparib and temozolomide. Whether enhancement of PARP inhibitor sensitivity with temozolomide is observed (✔) or not (✖) is indicated.
Jon Travers (818670)   +11 more
core   +1 more source

Temozolomide in combination with fotemustine in patients with metastatic melanoma

open access: yes, 2008
Purpose Temozolomide and fotemustine are both active drugs for treating metastatic melanoma. The present study was designed to assess the efficacy and safety of combination therapy with temozolomide + fotemustine in patients with metastatic ...
Tas, Faruk, Topuz, Erkan, Camlica, Hakan
core   +1 more source

List of temozolomide (TMZ)-mediated microRNAs.

open access: yes, 2016
List of temozolomide (TMZ)-mediated microRNAs.
Cheng-Wei Lin (1668613)   +8 more
core   +1 more source

USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA [PDF]

open access: yes, 2023
Disclosed are methods of synergistically inhibiting growth of a glioma cell comprising contacting the cell with temozolomide and TNFα, or with temozolomide, TNFα, and radiation.

core  

Mutations in the PIK3C2B, ERBB3, KIT, and MLH1 Genes and Their Relationship with Resistance to Temozolomide in Patients with High-Grade Gliomas

open access: yesBiomedicines
Introduction. The treatment for patients with high-grade gliomas includes surgical resection of tumor, radiotherapy, and temozolomide chemotherapy. However, some patients do not respond to temozolomide due to a methylation reversal mechanism by the ...
León Darío Ortiz Gómez   +6 more
doaj   +1 more source

Table_2_Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas.xlsx

open access: yes, 2023
IntroductionThe most important chemotherapy treatment for glioma patients is temozolomide. However, the development of drug resistance severely restricts the use of temozolomide.
Qiang Gu (330633)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy